ACS CAN Supports FDA’s Marketing Denial Order of Logic Technology Development
Washington, D,C. – The American Cancer Society Cancer Action Network (ACS CAN) and its partners submitted an amicus curiae (or friend-of-the-court) brief today in support of the U.S.